ArticleFrontiers in immunology2026

Targeting Bruton tyrosine kinase with acalabrutinib attenuates murine sclerodermatous chronic graft versus host disease.

Vasantharaja Raguraman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.